The heart-attack risks of arthritis painkillers Vioxx, Bextra and Celebrex have exposed a regulatory “house of cards” at the Food and Drug Administration, wrote Dr. Eric J. Topol, chairman of cardiovascular medicine at the Cleveland Clinic.
“Unbridled promotion exacerbated the public health problem,” Topol concluded. “The combination of mass promotion of a medicine with an unknown and suspect safety profile cannot be tolerated in the future.” Read more here. Topol’s Journal of American Medicine article: Arthritis Medicines and Cardiovascular Events?”House of Coxibs”
Background Links: alltheweb | Clusty | Google News | MSN Search | Teoma | Yahoo Search
Drug advertising has truly gone off the deep end. Driving down the beltline and seeing a nonsensical name on a billboard makes no sense.